Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Rodrigo Aliaga

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Actas Urologicas Espanolas|May 18, 2019
Safety of nivolumab in metastatic renal cell carcinoma patients: A real-life experience in a Spanish urology settingJ Amores Bermúdez, I Osman García, M Unda Urzáiz, et al.
Actas Urologicas Espanolas|October 21, 2022
Hormone sensitive protocol for metastatic prostate cancer, an updateJ L Álvarez Ossorio, M Rodrigo Aliaga, A Rodríguez Antolin, et al.
Actas Urologicas Espanolas|March 20, 2022
Non-metastatic castration-resistant prostate cancer: management recommendationsA Alcaraz Asensio, J L Alvarez Ossorio, J M Cozar Olmo, et al.
Cancer Medicine|September 10, 2025
Real World Evidence of Active Surveillance for Prostate Cancer in Spain; Midterm ResultsJ Rubio-Briones, A Borque-Fernando, L M Esteban Escaño, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Actas Urologicas Espanolas|May 18, 2019
Safety of nivolumab in metastatic renal cell carcinoma patients: A real-life experience in a Spanish urology settingJ Amores Bermúdez, I Osman García, M Unda Urzáiz, et al.
Actas Urologicas Espanolas|October 21, 2022
Hormone sensitive protocol for metastatic prostate cancer, an updateJ L Álvarez Ossorio, M Rodrigo Aliaga, A Rodríguez Antolin, et al.
Actas Urologicas Espanolas|March 20, 2022
Non-metastatic castration-resistant prostate cancer: management recommendationsA Alcaraz Asensio, J L Alvarez Ossorio, J M Cozar Olmo, et al.
Cancer Medicine|September 10, 2025
Real World Evidence of Active Surveillance for Prostate Cancer in Spain; Midterm ResultsJ Rubio-Briones, A Borque-Fernando, L M Esteban Escaño, et al.
Pageof 3